Create account

Coverage dated October 21, 2026 to October 24, 2026

Nationwide recall on these compound GLP-1 drugs

Headline from WOWK Charleston

The compounded GLP-1s are not FDA-approved nor name-brand.

WOWK Charleston's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

25 articles, oldest first.

  1. The Boston Globe

    Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met by approved name-brand drugs.

  2. WOWK Charleston

    Nationwide recall on these compound GLP-1 drugs (opens WOWK Charleston)

    Published

    WOWK Charleston's feed description

    The compounded GLP-1s are not FDA-approved nor name-brand.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Related updates

Separate coverage close to this update in time and subject.

Nationwide recall on these compound GLP-1 drugs | Since Then